Clinical trial
A Study for Patients With Type 1 Diabetes Mellitus
NCT00447213 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00447213 |
|---|---|
| Title | A Study for Patients With Type 1 Diabetes Mellitus |
| Official title | A Crossover Study to Evaluate the Efficacy and Safety of Preprandial Human Insulin Inhalation Powder (HIIP) Compared to Preprandial Injectable Insulin in Patients With Type 1 Diabetes Mellitus |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Alkermes, Inc. Industry |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 1 |
| Intervention type | Drug |
| Interventions | Insulin glargine, Human Insulin Inhalation Powder, Injectable Insulin |
| Enrollment | 70 |
| Start date | Apr 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Mar 14, 2007 |
| Last update posted | Oct 13, 2010 |
| Countries | Japan, Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: